The minimal important difference for target lobe volume reduction after endoscopic valve therapy

Area of Science:

• Pulmonology
• Medical Imaging
• Interventional Pulmonology

Background:

• Endoscopic valve therapy aims to improve lung function in emphysema patients through target lobe volume reduction (TLVR).
• Previously, a TLVR exceeding 350 mL was considered a positive treatment indicator.
• The precise TLVR threshold for meaningful clinical benefit after valve implantation remained unclear.

Purpose of the Study:

• To determine the minimal important difference (MID) for TLVR following endoscopic valve therapy in emphysema patients.
• To establish a clinically relevant TLVR threshold for treatment success.

Main Methods:

• 119 emphysema patients undergoing valve implantation were assessed for TLVR, FEV1, RV, and 6-MWD pre- and post-procedure.
• TLVR was quantified using CT scan analysis with specialized imaging software.
• MID for TLVR was calculated using anchor-based and distribution-based methods.

Main Results:

• Patients achieved a mean TLVR of 945 mL, with significant improvements in FEV1, RV, and 6-MWD.
• Linear regression and ROC analysis indicated an MID for TLVR between 890 and 1,070 mL.
• This range represents 49%-54% of the baseline total lung volume.

Conclusions:

• A TLVR of 49%-54% of the baseline total lung volume should be considered the clinically relevant threshold for treatment success.
• This finding provides a more precise metric for interpreting the efficacy of endoscopic valve therapy in emphysema.